Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…
Mental health company Talkspace has purchased Wisdo Health, an AI-powered platform for social health and peer support. The post Talkspace Acquires Peer Support Platform Wisdo Health appeared first on MedCity News.
At MedCity News’ INVEST Digital Health conference, healthcare experts explored strategies to mitigate automation bias — emphasizing the importance of vendor responsibility, use case-specific governance and clinician engagement. The post How Are Healthcare Leaders Tackling Automation Bias? appeared first on MedCity News.
Shirley Ryan AbilityLab Earns New Joint Commission Sustainability Award With support from Compass One Healthcare, Shirley Ryan AbilityLab has reached another milestone in its commitment to environmental stewardship. The Chicago-based rehabilitation hospital, renowned for treating patients with stroke, spinal cord, and brain injuries, has earned The Joint Commission’s new Sustainability Healthcare Certification. It is the…
This issue brief provides an overview of the potential impact not extending enhanced ACA premium tax credits could have on people with HIV and the Ryan White HIV/AIDS Program. Enhanced credits have improved insurance coverage affordability for millions of people, including those with HIV. People with HIV may be particularly vulnerable, given that they are…
Mientras Estados Unidos se dirigía hacia el cierre del gobierno, los republicanos acusaban repetidamente a los demócratas de forzar este cierre porque quieren que los inmigrantes que están en el país sin papeles tengan acceso a atención médica. “Los demócratas amenazan con cerrar todo el gobierno porque quieren otorgar cientos de miles de millones de…
This brief looks at premium changes for Medicare Part D stand-alone prescription drug plans between 2025 and 2026. For plans that were offered nationwide in 2025 and will continue to be offered in 2026, Part D enrollees in many states will see lower monthly premiums in 2026.
Improving no-show rates is not just about perfecting our reminders — it’s about redesigning the member experience from the ground up and creating systems that reflect and accommodate the realities of members’ lives. The post Turning Missed Appointments into Meaningful Member Action appeared first on MedCity News.
Healthcare and life sciences are about to face unprecedented AI-driven regulatory changes that will reshape everything from research and development to drug approval submissions. Here are 10 steps healthcare and life sciences organizations should take to strategically prepare. The post White House AI Action Plan: What Healthcare Leaders Must Do Now appeared first on MedCity…
[Sponsored] Clinical Architecture Founder and CEO Charlie Harp talked about how clinical data can be assessed and improved to build trust from the healthcare industry. The post The Future of AI in Healthcare Depends on Clinical Data Quality Assessment appeared first on MedCity News.